vix.ing · top · new · best · stats

Large‐Sample Evidence on Firms’ Year‐over‐Year MD&A Modifications

2010/12/16 by Stephen Brown, STEPHEN V. BROWN, Jennifer Wu Tucker +1 · 705 citations
Business, Management and Accounting · Chemistry · Economics, Econometrics and Finance · #Accounting #Auditing, Earnings Management, Governance #Biology #Business #Chemistry #Commission #Corporate Finance and Governance #Demographic economics #Earnings #Economics #Finance #Financial Markets and Investment Strategies #Financial economics #Monetary economics #Sample (material) #Stock (firearms) #Stock price

paper · doi:10.1111/j.1475-679x.2010.00396.x

published in Journal of Accounting Research 49(2), 309-346 (Wiley)

openalex publication_date 2010/12/16 · openalex created_date 2025/10/10 · openalex updated_date 2026/08/04

Abstract

ABSTRACT The Securities and Exchange Commission (SEC) has expressed concern about the informativeness of firms’ Management Discussion and Analysis (MD&A) disclosures. A firm's MD&A is potentially uninformative if it does not change appreciably from the previous year after significant economic changes at the firm. We introduce a measure for narrative disclosure—the degree to which the MD&A differs from the previous disclosure—and provide three findings on the usefulness of MD&A disclosure. First, firms with larger economic changes modify the MD&A more than those with smaller economic changes. Second, the magnitude of stock price responses to 10‐K filings is positively associated with the MD&A modification score, but analyst earnings forecast revisions are unassociated with the score, suggesting that investors—but not analysts—use MD&A information. Finally, MD&A modification scores have declined in the past decade even as MD&A disclosures have become longer; the price reaction to MD&A modification scores has also weakened, suggesting a decline in MD&A usefulness.

Citations

Cited by

Related